Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for EQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 57.16M
March 31, 2026 61.32M
December 31, 2025 30.28M
September 30, 2025 33.12M
June 30, 2025 11.50M
March 31, 2025 14.50M
December 31, 2024 22.58M
September 30, 2024 25.88M
June 30, 2024 33.30M
March 31, 2024 32.28M
December 31, 2023 40.87M
September 30, 2023 46.31M
June 30, 2023 48.38M
March 31, 2023 61.99M
December 31, 2022 71.02M
September 30, 2022 44.52M
Date Value
June 30, 2022 57.56M
March 31, 2022 68.82M
December 31, 2021 80.71M
September 30, 2021 90.69M
June 30, 2021 97.64M
March 31, 2021 104.08M
December 31, 2020 82.16M
September 30, 2020 90.54M
June 30, 2020 42.61M
March 31, 2020 47.68M
December 31, 2019 53.14M
September 30, 2019 62.24M
June 30, 2019 56.94M
March 31, 2019 61.61M
December 31, 2018 65.91M
September 30, 2018 4.982M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Fortress Biotech, Inc. 196.58M
Cue Biopharma, Inc. 17.39M
Legend Biotech Corp. 964.63M
Dianthus Therapeutics, Inc. 886.81M